STAR and neoplasm: In line with these findings, we demonstrated that expression of StAR is markedly higher in hormone-dependent, but not hormone-independent, BCs [23], suggesting that StAR, by providing the precursor of estrogens, acts as a tumor promoter in ER+/PR+ BCs.